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Abstract
Algorithms for computer-aided diagnosis of dementia based on structuralMRI have demonstrated high performance in the literature,
but are diﬃcult to compare as diﬀerent data sets and methodology were used for evaluation. In addition, it is unclear how the
algorithms would perform on previously unseen data, and thus, how they would perform in clinical practice when there is no real
opportunity to adapt the algorithm to the data at hand. To address these comparability, generalizability and clinical applicability
issues, we organized a grand challenge that aimed to objectively compare algorithms based on a clinically representative multi-
center data set. Using clinical practice as starting point, the goal was to reproduce the clinical diagnosis. Therefore, we evaluated
algorithms for multi-class classification of three diagnostic groups: patients with probable Alzheimer’s disease, patients with mild
cognitive impairment and healthy controls. The diagnosis based on clinical criteria was used as reference standard, as it was
the best available reference despite its known limitations. For evaluation, a previously unseen test set was used consisting of
354 T1-weighted MRI scans with the diagnoses blinded. Fifteen research teams participated with in total 29 algorithms. The
algorithms were trained on a small training set (n=30) and optionally on data from other sources (e.g., the Alzheimer’s Disease
Neuroimaging Initiative, the Australian Imaging Biomarkers and Lifestyle flagship study of aging). The best performing algorithm
yielded an accuracy of 63.0% and an area under the receiver-operating-characteristic curve (AUC) of 78.8%. In general, the
best performances were achieved using feature extraction based on voxel-based morphometry or a combination of features that
included volume, cortical thickness, shape and intensity. The challenge is open for new submissions via the web-based framework:
http://caddementia.grand-challenge.org.
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1. Introduction
In 2010, the number of people over 60 years of age living
with dementia was estimated at 35.6 million worldwide. This
number is expected to almost double every twenty years (Prince
et al., 2013). Accordingly, the cost of care for patients with
Alzheimer’s disease (AD) and other dementias is expected to
increase dramatically, making AD one of the costliest chronic
diseases to society (Alzheimer’s Association, 2014). Early and
accurate diagnosis has great potential to reduce the costs re-
lated to care and living arrangements as it gives patients access
to supportive therapies that can help them maintain their inde-
pendence for longer and delay institutionalization (Paquerault,
2012; Prince et al., 2011). In addition, early diagnosis supports
new research into understanding the disease process and devel-
oping new treatments (Paquerault, 2012; Prince et al., 2011).
While early and accurate diagnosis of dementia is challeng-
ing, it can be aided by assessment of quantitative biomarkers.
The five most commonly investigated biomarkers were recently
included in the revised diagnostic criteria for AD (McKhann
et al., 2011; Jack et al., 2011) and in the revised diagnostic cri-
teria for mild cognitive impairment (MCI) due to AD (Albert
et al., 2011). These five biomarkers can be divided into two
categories: 1) measures of brain amyloid, which include cere-
brospinal fluid (CSF) measures of Aβ42 and amyloid positron
emission tomography (PET) imaging, and 2) measures of neu-
ronal injury and degeneration, which include CSF tau mea-
surement, fluoro deoxyglucose (FDG) PET and structural MRI
(Jack et al., 2012). Of these biomarkers, structural MRI is very
important as it is widely available and non-invasive. Also, it is
a good indicator of progression to AD in an individual subject,
because it becomes abnormal in close temporal proximity to the
onset of the cognitive impairment (Jack et al., 2010, 2013).
Structural MRI data can be used to train computer-aided
diagnosis methods. These methods make use of machine-
learning and other multivariate data-analysis techniques that
train a model (classifier) to categorize groups (e.g., patients and
controls). Computer-aided diagnosis techniques use features
derived from neuroimaging or related data, and may therefore
benefit from the large amounts of neuroimaging data that have
become available over the last years. The techniques may im-
prove diagnosis as they can potentially make use of group dif-
ferences that are not noted during qualitative visual inspection
of brain imaging data, potentially leading towards an earlier
and more objective diagnosis than when using clinical crite-
ria (Klo¨ppel et al., 2012). In addition, computer-aided diagno-
sis algorithms can be used to 1) improve diagnosis in hospitals
with limited neurological and neuroradiological expertise, 2)
increase the speed of diagnosis, and 3) aid the recruitment of
specific, homogeneous patient populations for clinical trials in
pharmacological research (Klo¨ppel et al., 2012).
Structural-MRI-based computer-aided diagnosis methods for
dementia, mainly for AD and MCI, have previously shown
promising results in the literature. A few years ago, Cuingnet
et al. (2011) compared the performance of various feature ex-
traction methods (e.g., voxel-based features, cortical thick-
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ness, hippocampal shape and volume) for dementia classifi-
cation using a support vector machine (SVM) based on struc-
tural MRI. Using data from 509 subjects from the Alzheimer’s
Disease Neuroimaging Initiative (ADNI) cohort, three classi-
fication experiments were performed: 1) AD versus healthy
controls (CN), 2) patients with MCI versus CN, and 3) MCI
who had converted to AD within 18 months (MCI converters,
MCIc) versus MCI who had not converted to AD within 18
months (MCI non-converters,MCInc). For the AD/CN classifi-
cation, the best results were obtained with whole-brain methods
(voxel-based and cortical thickness) achieving 81% sensitivity
and 95% specificity for the best method. The performances
of the MCI/CN classifications were much lower than those of
AD/CN, and the MCIc/MCInc classifications yielded no perfor-
mances better than chance. A recent review paper by Falahati
et al. (2014) discussed the literature on AD classification and
MCI prediction. The research field of computer-aided diag-
nosis of dementia based on structural MRI is rather extensive,
as evidenced by this paper reviewing 50 papers with at least
50 subjects per diagnostic group. The reviewed papers mainly
trained a classification model on the AD/CN groups and sub-
sequently tested this model on both AD/CN and MCIc/MCInc
classifications. The paper concluded that classification meth-
ods are diﬃcult to compare, because the outcome is influ-
enced by many factors, such as feature extraction, feature se-
lection, robustness of the validation approach, image quality,
number of training subjects, demographics, and clinical diag-
nosis criteria. In general, the accuracy obtained for AD/CN
classification was 80-90%, and the accuracy for prediction of
MCI conversion is somewhat lower. To promote comparison
of algorithms, Sabuncu and Konukoglu (2014) published re-
sults based on six large publicly available data sets for AD
and other diseases (e.g., schizophrenia, autism). A compari-
son was performed using four feature extraction strategies, in-
cluding volumetric and cortical thickness features computed
with FreeSurfer (Fischl, 2012), and three types of machine
learning techniques (SVM, neighborhood approximation for-
est (Konukoglu et al., 2013), and relevance voxel machine
(Sabuncu and Van Leemput, 2012)). Using the ADNI database,
the accuracies ranged from 80-87% for AD/CN classification
and 58-66% for MCI/CN classification. The authors made all
processed data and computational tools available to promote ex-
tension of their benchmark results.
Taken together, these publications show very promising re-
sults of algorithms for computer-aided diagnosis of AD and
MCI. However, they are diﬃcult to compare as diﬀerent data
sets and methodology were used for evaluation. In addition,
it is unclear how the algorithms would perform on previously
unseen data, and thus, how they would perform in clinical prac-
tice when there is no opportunity to adapt the algorithm to the
data at hand. Adaptation of an algorithm would be necessary
if the algorithm had been trained or optimized on data that
are not representative for the data used in a clinical setting.
This seriously hampers clinical implementation of algorithms
for computer-aided diagnosis. In medical image analysis re-
search, issues related to comparability and clinical applicability
have been addressed in grand challenges1. Such grand chal-
lenges have the goal of comparing algorithms for a specific task
on the same clinically representative data using the same eval-
uation protocol. In such challenges, the organizers supply ref-
erence data and evaluation measures on which researchers can
evaluate their algorithms. For this work, we initiated a grand
1http://www.grand-challenge.org
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challenge on Computer-Aided Diagnosis of Dementia (CAD-
Dementia). The CADDementia challenge aims to objectively
compare algorithms for classification of AD and MCI based on
a clinically representative multi-center data set. We recently
organized a workshop at the 17th International Conference on
Medical Image Computing and Computer-Assisted Interven-
tions (MICCAI). At this workshop, the methods and results of
the algorithms were presented by the 15 teams that originally
participated in the challenge.
In the CADDementia challenge, we evaluated algorithms
that made amulti-class classification of three diagnostic groups:
patients with AD, patients with MCI and CN. The algo-
rithms covered the complete image-processing and classifica-
tion pipeline starting from structural MRI images. The current
clinical diagnosis criteria for AD and MCI (McKhann et al.,
2011; Petersen, 2004) were used as the reference standard. Al-
though MCI is known to be heterogeneous, as some of the pa-
tients will convert to AD and others will not, it is considered
to be one diagnostic entity according to these clinical diagnosis
criteria. Hence, in this challenge we did not address prediction
of MCI progression, but focused on diagnosis as a crucial first
step. Regarding diagnostic classification, binary AD/CN clas-
sification overestimates true clinical performance as the most
diﬃcult to diagnose patients are left out. Therefore we chose
to stay close to the clinical problem and address the three-class
classification problem.
An evaluation framework was developed consisting of eval-
uation measures and a reference data set. All methodological
choices for the evaluation framework are based on considera-
tions related to our aim to take a step towards clinical imple-
mentation of algorithms for computer-aided diagnosis of de-
mentia. This can be summarized in three key points: com-
parability, generalizability, and clinical applicability. First, by
evaluating all algorithms using the same data set and evaluation
methods, the results of the algorithms were better comparable.
Second, by providing a previously unseen multi-center data set
with blinded ground truth diagnoses, overtraining was avoided
and generalizability of the algorithms is promoted. Third, ac-
cording to the current clinical standards, a multi-class diagnosis
of AD, MCI and CN was evaluated. The data for the evaluation
framework consisted of clinically-representative T1-weighted
MRI scans acquired at three centers. For testing the algorithms,
we used scans of 354 subjects with the diagnoses blinded to the
participants. Because the aim of this challenge was to evaluate
the performance in a clinical situation, when not much data are
available, we decided to make only a small training set avail-
able. This training set consisted of 30 scans equally represent-
ing the three data-supplying centers and the diagnostic groups.
The diagnostic labels for the training set were made available.
For both training and test data, age and sex were provided.
In addition to the provided training data, teams were encour-
aged to use training data from other sources. For this purpose,
most algorithms used data from the Alzheimer’s Disease Neu-
roimaging Initiative (ADNI)2 or from the Australian Imaging
Biomarker and Lifestyle flagship study of aging (AIBL)3.
In this article, we present the CADDementia challenge for
objective comparison of computer-aided diagnosis algorithms
for AD and MCI based on structural MRI. The article describes
the standardized evaluation framework consisting of evaluation
measures and a multi-center structural MRI data set with clin-
ical diagnoses as reference standard. In addition, this paper
2http://adni.loni.usc.edu
3http://aibl.csiro.au
presents the results of 29 algorithms for classification of de-
mentia developed by 15 international research teams that par-
ticipated in the challenge.
2. Evaluation framework
In this section, we describe our evaluation framework includ-
ing the data set, the reference standard, the evaluation measures
and the algorithm ranking methods.
2.1. Web-based evaluation framework
The evaluation framework as proposed in this work is made
publicly available through a web-based interface4. From this
protected web site, the data and the evaluation software are
available for download. The data available for download are,
for the training set: a total of 30 structural MRI scans from the
probable AD, MCI and CN groups including diagnostic label,
age, sex and scanner information; and for the test set: 354 struc-
tural MRI scans from the probable AD, MCI and CN groups
including age, sex and scanner information. The data set and
the evaluation measures are detailed in the following sections.
Everyone who wishes to validate their algorithm for classifica-
tion of AD, MCI and CN can use the data set for validation.
To be allowed to download the data, participants are required
to sign a data usage agreement and to send a brief description
of their proposed algorithm. The predictions and a short ar-
ticle describing the algorithm are submitted via the web site4.
The algorithms are validated with the software described in the
following sections. The web site remains open for new submis-
sions to be included in the ranking.
2.2. Data
A multi-center data set was composed consisting of imag-
ing data of 384 subjects from three medical centers: VU Uni-
versity Medical Center (VUMC), Amsterdam, the Netherlands;
Erasmus MC (EMC), Rotterdam, the Netherlands; University
of Porto / Hospital de Sa˜o Joa˜o (UP), Porto, Portugal. The
data set contained structural T1-weighted MRI (T1w) scans of
patients with the diagnosis of probable AD, patients with the
diagnosis of MCI, and CN without a dementia syndrome. In
addition to the MR scans, the data set included demographic
information (age, sex) and information on which institute the
data came from. Within the three centers, the data sets of the
three classes had a similar age and sex distribution.
The data characteristics are listed in Table 1 and the sizes of
the complete data set, training set and test set are listed in Table
2. Most of the data were used for evaluation of performance:
the test set. Only after the workshop, we released the class
sizes of the test set, marked with a * in Table 2. Therefore
only the prior for each class (∼1/3) was known to the authors
of the algorithms in this paper. A small training data set with
diagnostic labels was made available, which consisted of 30
randomly chosen scans distributed over the diagnostic groups.
Suitable data from other sources could be used for training (see
Sec. 3.1).
2.3. Reference standard
The clinical diagnosis was used as the reference standard in
this evaluation framework. The data were acquired either as
part of clinical routine or as part of a research study at the three
4http://caddementia.grand-challenge.org
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Table 1: Data characteristics. ASSET: array spatial sensitivity encoding technique, FSPGR: fast spoiled gradient-recalled echo, IR: inversion
recovery, MPRAGE: magnetization prepared rapid acquisition gradient echo, TE: echo time, TI: inversion time, TR: repetition time
VUMC EMC UP
Scanner
3T, GE Healthcare
3T, GE Healthcare Protocol 1: Discovery MR750 3T, Siemens
Signa HDxt Protocol 2: Discovery MR750 Trio A Tim
Protocol 3: HD platform
Sequence 3D IR FSPGR 3D IR FSPGR 3D MPRAGE
Scan parameters (TI/TR/TE)
Protocol 1: 450ms / 7.9ms / 3.1ms
450ms / 7.8ms / 3.0ms Protocol 2: 450ms / 6.1ms / 2.1ms 900ms / 2300ms / 3.0ms
Protocol 3: 300ms / 10.4ms / 2.1ms
Parallel imaging
Protocol 1: Yes (ASSET factor=2)
Yes (ASSET factor=2) Protocol 2: Parallel imaging: No No
Protocol 3: Parallel imaging: No
Resolution
Protocol 1: 0.9x0.9x1.0 mm (sagittal)
0.9x0.9x1 mm (sagittal) Protocol 2: 0.9x0.9x0.8 mm (axial) 1x1x1.2 mm (sagittal)
Protocol 3: 0.5x0.5x0.8 mm (axial)
Number of scans 180 174 30
Age Mean (Std)
Overall 62.2 (5.9) years 68.6 (7.8) years 67.8 (9.1) years
CN 62.1 (6.0) years 65.5 (7.3) years 64.1 (8.8) years
MCI 62.5 (5.5) years 73.1 (5.5) years 70.0 (8.5) years
AD 62.0 (6.0) years 67.2 (8.4) years 64.6 (7.8) years
Percentage of males
Overall 59 % 63 % 50 %
CN 62 % 61 % 40 %
MCI 68 % 69 % 60 %
AD 47 % 57 % 50 %
Table 2: Sizes of the complete data set, training set and test set, distributed over the three data-supplying centers and the three classes. The
numbers in the columns marked by a * were unknown to the authors of the algorithms discussed in this paper.
Complete data set
nAD* nMCI* nCN* n
VUMC 60 60 60 180
EMC 42 61 71 174
UP 10 10 10 30
Total 112 131 141 384
Training data
nAD nMCI nCN n
VUMC 5 4 5 14
EMC 3 4 6 13
UP 1 1 1 3
Total 9 9 12 30
Test data
nAD* nMCI* nCN* n
VUMC 55 56 55 166
EMC 39 57 65 161
UP 9 9 9 27
Total 103 122 129 354
centers. All patients underwent neurological and neuropsycho-
logical examination as part of their routine diagnostic work up.
The clinical diagnosis was established by consensus of a mul-
tidisciplinary team. Patients with AD met the clinical criteria
for probable AD (McKhann et al., 1984, 2011). MCI patients
fulfilled the criteria specified by Petersen (2004): i.e. memory
complaints, cognitive impairment in one or multiple domains
confirmed by neuropsychological testing, not demented, intact
global cognitive function, clinical dementia rating score=0.5.
No hard threshold values were used, but all mentioned crite-
ria were considered. Subjects with psychiatric disorder or other
underlying neurological disease were excluded. Center-specific
procedures are specified in the following sections.
2.3.1. VUUniversity Medical Center (VUMC), Amsterdam, the
Netherlands
Patients with AD, patients with MCI and controls with sub-
jective complaints were included from the memory-clinic based
Amsterdam Dementia Cohort (van der Flier et al., 2014). The
protocol for selection of patients and controls was the same as
used by Binnewijzend et al. (2013). Controls were selected
based on subjective complaints and had at least 1 year of follow-
up with stable diagnosis. For the controls, the findings from all
investigations were normal; they did not meet the criteria for
MCI. The patients’ T1w-scans showed no stroke or other ab-
normalities. All patients gave permission for the use of the data
for research.
2.3.2. Erasmus MC (EMC), Rotterdam, the Netherlands
From the Erasmus MC, the data were acquired either as part
of clinical routine or as part of a research study. All patients
were included from the outpatient memory clinic. Diagnostic
criteria for AD andMCI (Papma et al., 2014)were as mentioned
above. Healthy control subjects were volunteers recruited in
research studies and did not have any memory complaints. All
subjects signed informed consent and the study was approved
by the local medical ethical committee.
2.3.3. University of Porto / Hospital de Sa˜o Joa˜o (UP), Porto,
Portugal
The majority of the included patients were included from the
outpatient dementia clinic of Hospital de Sa˜o Joa˜o (Porto, Por-
tugal). Two patients with AD were referred from external insti-
tutions for a second opinion. In addition, healthy control sub-
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Table 3: Confusion matrix for a three-class classification problem
True class
c0 c1 c2
C0 n0,0 n0,1 n0,2
Hypothesized class C1 n1,0 n1,1 n1,2
C2 n2,0 n2,1 n2,2
Column totals: n0 n1 n2
jects were volunteers recruited in research studies. All subjects
provided consent to be included in this study.
2.4. Data preprocessing
The T1wMRI data was anonymized and facial features were
masked (Leung et al., 2014). All anonymized scans were vi-
sually inspected to check if no brain tissue was accidentally re-
moved by the facial masking. Skull stripping was performed by
the participants themselves, if needed for their algorithm. Next
to the original anonymized T1w scans, we provided these scans
after non-uniformity correction with N4ITK (Tustison et al.,
2010) using the following settings: shrink factor = 4, number
of iterations = 150, convergence threshold = 0.00001, initial b-
spline mesh resolution= 50 mm. Images were stored in NIfTI-1
file format5.
2.5. Evaluation measures
The performance of the algorithms was quantified by
the classification accuracy, area under the receiver-operating-
characteristic (ROC) curve (AUC) and the true positive fraction
for the three classes. The performance was evaluated on all 354
test subjects (ALL) and in addition per data-providing center
(VUMC, EMC, UP).
2.5.1. Accuracy for multi-class classification
Classification accuracy is in case of a binary design defined
as the number of correctly classified samples divided by the
total number of samples. For extending the accuracy measure
to three-class classification, there are two main options (Hand
and Till, 2001). The diﬀerence between these is whether or
not the diﬀerence between the two other classes is taken into
account when the performance for one class is assessed.
To determine a simple measure of accuracy, all diagonal ele-
ments of the confusion matrix (Table 3), the true positives (tp)
and true negatives (tn), are divided by the total number of sam-
ples (n):
accuracy =
tp + tn
n
=
n0,0 + n1,1 + n2,2
n0 + n1 + n2
. (1)
The alternative, the average accuracy,
accuracyaverage =
1
L
L−1∑
i=0
tpi + tni
n
=
1
L
L−1∑
i=0
ni,i +
∑L−1
j=0, j!i
∑L−1
k=0,k!i n j,k
n
,
(2)
assesses the accuracy separately for each class without distin-
guishing between the two other classes. For calculation of the
accuracy for i = 0, the true positive samples (tpi) are n0,0. The
5http://nifti.nimh.nih.gov
true negative samples in this case (tni) are n1,1, n1,2, n2,1 and
n2,2. The separate per-class accuracies are averaged to yield the
final accuracy. L denotes the number of classes.
Eq. 2 is mainly applicable when the class sizes are very dif-
ferent. In this evaluation framework, we use the accuracy in
Eq. 1 as it provides a better measure for the overall classifica-
tion accuracy (Hand and Till, 2001).
2.5.2. AUC for multi-class classification
The performance of a binary classifier can be visualized as
an ROC curve by applying a range of thresholds on the prob-
abilistic output of the classifier and calculating the sensitivity
and specificity. The AUC is a performance measure which
is equivalent to the probability that a randomly chosen posi-
tive sample will have a higher probability of being positively
classified than a randomly chosen negative sample (Fawcett,
2006). The advantage of ROC analysis - and accordingly the
AUC measure - is that the performance of a classifier is mea-
sured independently of the chosen threshold. When more than
two dimensions are used the ROC-curve becomes more com-
plex. With L classes, the confusion matrix consists of L2 el-
ements: L diagonal elements denoting the correct classifica-
tions, and L2 − L oﬀ-diagonal elements denoting the incorrect
classifications. For ROC analysis, the trade-oﬀ between these
oﬀ-diagonal elements is varied. For three-class classification,
there are 32 − 3 = 6 oﬀ-diagonal elements, resulting in a 6-
dimensional ROC-curve. Therefore, for simplicity, multi-class
ROC analysis is often generalized to multiple per-class or pair-
wise ROC curves (Fawcett, 2006).
Similarly to accuracy in the previous section, the multi-class
AUC measure can be defined in two ways. The diﬀerence be-
tween the two definitions is whether or not the third class is
taken into account when the diﬀerence between a pair of classes
is assessed.
First, Provost and Domingos (2001) calculate the multi-class
AUC by generating an ROC curve for every class and measur-
ing the AUCs. These per-class AUCs are averaged using the
class priors p(ci) as weights:
AUC1 =
L−1∑
i=0
AUC(ci) · p(ci). (3)
This method has the advantage that the separate ROC curve can
be easily generated and visualized. The method calculates an
AUC for every class separately, which is sensitive for the class
distributions. Even though the class priors are used in averag-
ing, the total AUC still depends on the class sizes.
Second, Hand and Till (2001) proposed a diﬀerent method
for multi-class AUC which is based on calculating an AUC for
every pair of classes, without using information from the third
class. The method is based on the principle that the AUC is
equivalent to the probability that a randomly chosen member
of class ci will have a larger estimated probability of belonging
to class Ci than a randomly chosen member of class c j. Us-
ing this principle, the AUC can also be calculated directly from
the ranks of test samples instead of first calculating the ROC
curves. To achieve this, the class ci and c j test samples are
ranked in increasing order of the output probability for class Ci.
Let S i be the sum of the ranks of the class ci test samples. The
AUC for a class ci given another class, Aˆ(ci|c j), is then given by
Aˆ(ci|c j) =
S i − ni(ni + 1)/2
nin j
, (4)
see Hand and Till (2001) for the complete derivation.
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For situations with three or more classes, Aˆ(ci|c j) ! Aˆ(c j|ci).
Therefore, the average of both is used:
Aˆ(ci, c j) =
Aˆ(ci|c j) + Aˆ(c j|ci)
2
. (5)
The overall AUC is obtained by averaging this over all pairs of
classes:
AUC2 =
2
L(L − 1)
L−1∑
i=0
i∑
j=0
Aˆ(ci, c j), (6)
in which the number of pairs of classes is L(L−1)2 .
In contrast to the accuracy, AUC measurement does not re-
quire a threshold on the classifier’s output probabilities and
therefore the AUC generally does not rely on the class priors
(Hand and Till, 2001). However, the first multi-class approach
is dependent on the class priors as these are used for averaging
the per-class AUCs. Therefore for this challenge, the second
approach for AUC was adopted (Fawcett, 2006).
2.5.3. True positive fraction
For binary classifications in computer-aided diagnosis, often
the sensitivity and the specificity are reported in addition to the
accuracy. For this multi-class application, the true positive frac-
tions (TPF) for the three classes provide the same information:
TPFi =
ni,i
ni
, i ∈ 0, 1, 2. (7)
The TPF for the diseased class (TPFAD; TPFMCI ) can be inter-
preted as the two-class sensitivity, and the TPF for the control
group equals the two-class specificity.
2.6. Submission guidelines
In this challenge, the participating teams were allowed to
submit up to five algorithms. Submitting the diagnostic label
for each sample of the test set was obligatory. Additionally, the
output probabilities for each label were requested but this was
optional to not rule out approaches that do not produce proba-
bilistic outcomes. Every team had to write one full workshop
paper describing their algorithms in the style of Lecture Notes
in Computer Science.
2.7. Final results and ranking
For every algorithm, a confusion matrix was made based on
the test data. Accuracy (Eq. 1) and the TPFi (Eq. 7) for the
three classes were calculated from the diagnostic labels. For
every class, an ROC curve and per-class AUCs were calcu-
lated from the output probabilities reduced to a binary solution,
e.g. AD versus non-AD, showing the ability of the classifier
to separate that class from the other two classes. An overall
AUC was calculated using Eqs. 4-6. Confidence intervals on
the accuracy, AUC and TPF were determined with bootstrap-
ping on the test set (1000 resamples). To assess whether the
diﬀerence in performance between two algorithms was signifi-
cant, theMcNemar test (Dietterich, 1996) was used. Evaluation
measures were implemented in Python scripting language (ver-
sion 2.7.6) using the libraries Scikit-learn6 (version 14.1) and
Scipy7 (version 14.0).
If an algorithm failed to produce an output for certain sub-
jects, these subjects were considered misclassified as a fourth
6http://scikit-learn.org
7http://www.scipy.org
class. This fourth class was considered in the calculation of all
performance measures. For calculation of the per-class ROC
curves, sensitivity and specificity were determined on the sub-
jects that were classified by the algorithm and subsequently
scaled to the total data set to take missing samples into account.
The participating algorithms were ranked based on accuracy
of diagnosing the cases in the test set. Algorithms for which
output probabilities were available were also ranked based on
the AUC of diagnosing the cases in the test set. The algorithm
with the best accuracy (rank=1) on the test set, was considered
the winning algorithm. In case two or more algorithms had
equal accuracies, the average rank was assigned to these algo-
rithms.
3. MICCAI 2014 workshop
The evaluation framework was launched in March 2014 and
the deadline for the first submissions was in June 2014. The
evaluation framework and the results of the first participating al-
gorithms were presented at the Challenge on Computer-Aided
Diagnosis of Dementia Based on Structural MRI Data work-
shop that was organized on September 18th 2014 in conjunction
with the 17th International Conference onMedical Image Com-
puting and Computer Assisted Intervention (MICCAI) confer-
ence in Boston (USA).
We invited around 100 groups from academia and industry by
email to participate in the challenge. The challenges were ad-
vertised by the MICCAI organizers as well. Eighty-one teams
made an account on the web site, of which 47 sent a data usage
agreement and a brief description of the proposed algorithm,
which was required for downloading the data. Finally, 16 teams
submitted results, of which 15 were accepted for participation
in the workshop. One team was excluded from participation be-
cause their workshop submission did not meet the requirements
and because they only submitted results for AD/CN classifica-
tion. The 15 participating teams submitted a total of 29 algo-
rithms. These algorithms are described in Section 3.2. More
details can be found in the short articles that all authors submit-
ted for the workshop (Bron et al., 2014).
3.1. Training data from other sources
In addition to the provided training data set of 30 scans,
other sources of training data could be used by the partici-
pants. All algorithms except for two were trained on data
from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
database8. The ADNI was launched in 2003 by the National
Institute on Aging (NIA), the National Institute of Biomedi-
cal Imaging and Bioengineering (NIBIB), the Food and Drug
Administration (FDA), private pharmaceutical companies and
non-profit organizations, as a $60 million, 5-year public-private
partnership. The primary goal of ADNI has been to test whether
serial magnetic resonance imaging (MRI), positron emission
tomography (PET), other biological markers, and clinical and
neuropsychological assessment can be combined to measure
the progression of mild cognitive impairment (MCI) and early
Alzheimer’s disease (AD). Determination of sensitive and spe-
cific markers of very early AD progression is intended to aid re-
searchers and clinicians to develop new treatments and monitor
their eﬀectiveness, as well as lessen the time and cost of clin-
ical trials. For up-to-date information, see www.adni-info.org.
8http://adni.loni.usc.edu
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Acquisition of these data had been performed according to the
ADNI acquisition protocol (Jack et al., 2008).
Two teams additionally trained on data from the Australian
Imaging Biomarkers and Lifestyle (AIBL) flagship study of
ageing9 funded by the Commonwealth Scientific and Industrial
Research Organisation (CSIRO). These data were collected by
the AIBL study group. AIBL study methodology has been re-
ported previously (Ellis et al., 2009).
3.2. Algorithms
In this section, the 29 algorithms submitted by 15 teams are
summarized. In Table 4, an overview of the algorithms is pre-
sented including a listing of the size of the used training set and
the performance on the provided 30 training scans.
3.2.1. Abdulkadir et al.
Algorithm: Abdulkadir (Abdulkadir et al., 2014)
Features: Voxel-based morphometry (VBM) of gray matter
(GM).
Classifier: Radial-basis kernel SVM.
Training data: 1289 ADNI subjects and 140 AIBL subjects.
The 30 training subjects provided by the challenge were
used for parameter selection.
Feature selection: SVM significance maps (Gaonkar and Da-
vatzikos, 2013).
Confounder correction: Yes, for age, sex and intracranial vol-
ume (ICV) using kernel regression.
Automatic: Yes. Registration requiredmanual intervention for
some subjects.
Computation time: 1 hour per subject.
3.2.2. Amoroso et al.
Algorithm: Amoroso (Amoroso et al., 2014)
Features: Volume features (FreeSurfer) and intensity features
of the peri-hippocampal region (mean, standard deviation,
kurtosis, and skewness).
Classifier: Back propagation neural network (1 hidden layer,
10 neurons). For every pairwise classification, 100 net-
works were trained on 50 randomly selected features. For
final classification, the output scores were averaged.
Training data: 258 ADNI subjects + the 30 training subjects.
Feature selection: Unsupervised filter based on correlation
and linear dependencies.
Confounder correction: -
Automatic: Yes.
Computation time: 13 hours per subject, of which 12 hours
were due to FreeSurfer processing time.
3.2.3. Ca´rdenas-Pen˜a et al.
Algorithm: Ca´rdenas-Pen˜a (Ca´rdenas-Pen˜a et al., 2014)
Features: Features were based on similarities in MRI inten-
sities between subjects. As a first step, similarities be-
tween slices of a subject’s scan were calculated along each
axis resulting in an interslice kernel (ISK) matrix. Second,
pairwise similarities between the subjects’ ISK matrices
were computed using the Mahalanobis distance. Third,
the dependence between the resulting matrix of the previ-
ous step and the class labels was optimized using a kernel
centered alignment function. The eigenvalues of the re-
sulting matrix were used as features.
9http://aibl.csiro.au
Classifier: Radial-basis kernel SVM.
Training data: 451 ADNI subjects.
Feature selection: -
Confounder correction: -
Automatic: Yes.
Computation time: 22.3 seconds per subject.
3.2.4. Dolph et al.
Algorithm: Dolph (Dolph et al., 2014)
Features: Volume ratio of white matter (WM) and CSF for ax-
ial slices.
Classifier: Radial-basis kernel SVM.
Training data: The 30 training subjects.
Feature selection: SVM wrapper.
Confounder correction: -
Automatic: Yes, but parameters for skull stripping and tissue
segmentation were set manually.
Computation time: 30 minutes per subject.
3.2.5. Eskildsen et al.
Algorithm: Eskildsen (Eskildsen et al., 2014, 2015):
Features: Volume and intensity features of the hippocampus
(HC) and entorhinal cortex (ERC) were calculated with
Scoring by Non-local Image Patch Estimator (SNIPE). By
comparing small image patches to a training library, this
method segmented these brain regions and computed a
grading value per voxel reflecting the proximity between a
patch and the classes. As features, the volumes and aver-
age grading values for HC and ERC were used.
Cortical thickness was computed with Fast Accurate Cor-
tex Extraction (FACE). As features, the mean cortical
thickness was used in regions with large diﬀerences in cor-
tical thickness between the classes.
These features were combined:
1. Eskildsen-FACEADNI1: Volume, intensity and corti-
cal thickness features
2. Eskildsen-ADNI1: Volume and intensity features
3. Eskildsen-FACEADNI2: Volume, intensity and corti-
cal thickness features
4. Eskildsen-ADNI2: Volume and intensity features
5. Eskildsen-Combined: A combination of the other
four methods by averaging the posterior probabilities
Classifier: Sparse logistic regression. Ensemble learning was
used to combine twenty-five models that were trained us-
ing diﬀerent parameters and diﬀerent sampling of the data.
Training data:
1. Eskildsen-FACEADNI1: 794 ADNI1 subjects
2. Eskildsen-ADNI1: 794 ADNI1 subjects
3. Eskildsen-FACEADNI2: 304 ADNI2 subjects
4. Eskildsen-ADNI2: 304 ADNI2 subjects
5. Eskildsen-Combined: 794 ADNI1 and 304 ADNI2
Regression parameters were optimized on the 30 training
subjects.
Feature selection: -
Confounder correction: Yes, for age, sex and diﬀerences in
class priors.
Automatic: Yes.
Computation time: 55 minutes per subject.
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Table 4: Overview of the participating algorithms. The training accuracy was computed on the 30 training subjects by training on the data from
diﬀerent sources only. As indicated below, three algorithms instead trained on all data using 5-fold or 10-fold cross-validation.
Algorithm Features Classifier
Size Training
training data accuracy [%]
1 Abdulkadir VBM SVM 1492 60
2 Amoroso Volume and intensity relations Neural network 288 67 5-fold
3 Ca´rdenas-Pen˜a Raw intensities SVM 451 83
4 Dolph Volumes SVM 30 80 10-fold
5 Eskildsen-ADNI1 Volume and intensity relations Regression 794 77
6 Eskildsen-ADNI2 Volume and intensity relations Regression 304 70
7 Eskildsen-Combined Volume, thickness and intensity relations Regression 1098 73
8 Eskildsen-FACEADNI1 Volume, thickness and intensity relations Regression 794 70
9 Eskildsen-FACEADNI2 Volume, thickness and intensity relations Regression 304 67
10 Franke VBM Regression 591 90
11 Ledig-ALL Volume, thickness and intensity relations Random forest 734 68
12 Ledig-CORT Cortical thickness Random forest 734 58
13 Ledig-GRAD Intensity relations Random forest 734 67
14 Ledig-MBL Intensity relations Random forest 734 66
15 Ledig-VOL Volumes Random forest 734 56
16 Moradi VBM SVM 835 77
17 Routier-adni Shapes Regression 539 50
18 Routier-train Shapes Regression 539 73
19 Sarica Volume and thickness SVM 210 70
20 Sensi Intensity relations Random forest, SVM 581 73
21 Smith Volume and raw intensities Regression 189 80
22 Sørensen-equal Volume, thickness, shape, intensity relations LDA 679 73
23 Sørensen-optimized Volume, thickness, shape, intensity relations LDA 679 80
24 Tangaro Volume and thickness SVM 190 73 5-fold
25 Wachinger-enetNorm Volume, thickness and shape Regression 781 73
26 Wachinger-man Volume, thickness and shape Regression 781 67
27 Wachinger-step1 Volume, thickness and shape Regression 781 77
28 Wachinger-step1Norm Volume, thickness and shape Regression 781 77
29 Wachinger-step2 Volume, thickness and shape Regression 781 80
3.2.6. Franke et al.
Algorithm: Franke (Franke and Gaser, 2014)
Features: VBM of GM and WM.
Classifier: Relevance vector regression. An age prediction
model was trained on healthy controls. Classification of
AD, MCI and CN was performed by thresholding the age
diﬀerence between the predicted age and the real age.
Training data: 561 healthy subjects (IXI cohort10). The age
diﬀerence threshold was optimized on the 30 training sub-
jects.
Feature selection: Principal component analysis (PCA).
Confounder correction: Yes. Age was used in the modeling.
Separate models were trained for males and females.
Automatic: Yes, except for the optimization of the age diﬀer-
ence threshold.
Computation time: 10 minutes per subject.
3.2.7. Ledig et al.
Algorithm: Ledig (Ledig et al., 2014):
Features: Five feature sets were used:
1. Ledig-VOL: Volumes of regions-of-interest (ROIs)
obtained with multi-atlas label propagation
and expectation-maximization-based refinement
(MALP-EM).
2. Ledig-CORT: Cortical thickness features (mean and
standard deviation) and surface features (surface
area, relative surface area, mean curvature, Gaussian
curvature) for the whole cortex and cortex regions.
10http://www.brain-development.org
3. Ledig-MBL: Features describing the manifold-based
learning (MBL) space. The manifold was trained on
intensity texture descriptors for 1701 ADNI subjects.
4. Ledig-GRAD: Intensity patterns in patches. Grading
features were learned using data of 629 ADNI and
the 30 training subjects. The method was based on
SNIPE (Eskildsen et al., 2014).
5. Ledig-ALL: A combination of all features above.
Classifier: Random forest classifier.
Training data: 734 ADNI subjects.
Feature selection: Only for Ledig-MBL and Ledig-Grad.
Ledig-MBL: PCA and sparse regression using local bi-
nary intensity patterns and mini mental-state examination
(MMSE) scores of 292 ADNI subjects. Ledig-Grad: elas-
tic net sparse regression.
Confounder correction: -
Automatic: Yes.
Computation time: 4 hours per subject.
3.2.8. Moradi et al.
Algorithm: Moradi (Moradi et al., 2014)
Features: VBM of GM.
Classifier: Transductive SVM. Unsupervised domain adapta-
tion was used to adapt the ADNI data to the 30 train-
ing sets. To increase both class separability and within-
class clustering, low density separation was applied to
both labeled and unlabeled data. The SVM used a graph-
distance derived kernel. The classifications were repeated
101 times and combined with majority vote. Classification
was performed in two stages: 1) AD/CN classification, 2)
a further division of AD/MCI and CN/MCI.
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Training data: 835 ADNI subjects.
Feature selection: Elastic net logistic regression.
Confounder correction: Yes. Age eﬀects were removed with
linear regression.
Automatic: Yes.
Computation time: 10 minutes per subject.
3.2.9. Routier et al.
Algorithm: Routier (Routier et al., 2014)
Features: Features derived from shape models of 12 brain
structures: caudate nucleus, putamen, pallidum, thalamus,
hippocampus and amygdala of each hemisphere. The seg-
mentations were obtained with FreeSurfer. 3D triangular
meshes of the shapes were obtainedwith amarching-cubes
algorithm. Anatomical models of the shapes were built for
AD, MCI and CN using Deformetrica11 (Durrleman et al.,
2014). The shape models were registered to the test sub-
jects, thus computing the likelihood of the data for each
model.
Classifier: Maximum-likelihood regression.
Training data: 509 ADNI subjects.
Thresholds were optimized on:
1. Routier-adni: the ADNI data
2. Routier-train: the 30 training sets
Feature selection: -
Confounder correction: -
Automatic: Yes.
Computation time: 4 days for training the anatomical models
and additionally 11 hours per subject.
3.2.10. Sarica et al.
Algorithm: Sarica (Sarica et al., 2014)
Features: Volume and cortical thickness features (FreeSurfer).
Classifier: Radial-basis kernel SVM. Pairwise classifications
were combined with voting.
Training data: 210 ADNI subjects. The 30 training sets were
used for model selection.
Feature selection: Three methods (correlation filter, random
forest filter, and SVM wrapper) and their combination
were evaluated. The models with best performance on
the 30 training subjects were selected: the methods with-
out ICV correction using the random forest filter (AD/CN,
AD/MCI) and the correlation filter (CN/MCI).
Confounder correction: Yes. Age and sex were included as
features. Experiments were performed with and without
ICV correction.
Automatic: Yes, except for the model selection.
Computation time: 5 hours per subject.
Note: Three test subjects were excluded as FreeSurfer failed.
11http://www.deformetrica.org
3.2.11. Sensi et al.
Algorithm: Sensi (Sensi et al., 2014)
Features: Intensity and textural features of cuboid regions in
the medial temporal lobe. The cuboid regions were placed
around the entorhinal cortex, perirhinal cortex, hippocam-
pus, and parahippocampal gyrus. In addition, two con-
trol regions were placed that are relatively spared by AD
(rolandic areas). In each region, voxel intensities were nor-
malized for each tissue by the tissue mean calculated in
an additional cuboid region positioned around the corpus
callosum in a reference template. To obtain the features,
the voxels in the cuboid volumes were processed with 18
filters (e.g., Gaussian mean, standard deviation, range, en-
tropy, mexican hat) with diﬀerent voxel radii.
Classifier: Radial-basis kernel SVM and random forest clas-
sifier, combined by the weighted mean. Using probability
density functions estimated on the 30 training subjects, the
output probabilities were mapped to the classes.
Training data: 551 ADNI subjects + the 30 training subjects.
For the ADNI data, MCIc patients were included in the
AD group.
Feature selection: Random forest classifier.
Confounder correction: -
Automatic: Yes.
Computation time: 45 minutes per subject.
3.2.12. Smith et al.
Algorithm: Smith (Smith et al., 2014)
Features: Surface area, volume and fragility of a thresholded
ROI containing mainly the WM. The fragility originates
from network theory and measures how close the structure
is from breaking apart into smaller components.
Classifier: Multinomial logistic regression.
Training data: 189 ADNI subjects + the 30 training subjects.
Feature selection: -
Confounder correction: Yes. Age was used as a feature. Sep-
arate thresholds for males and females were used for the
WM ROI.
Automatic: Yes, except for the optimization of the threshold
for the WM ROI.
Computation time: 7-24 minutes per subject.
3.2.13. Sørensen et al.
Algorithm: Sørensen (Sørensen et al., 2014)
Features: Five types of features were combined: 1) volumes
of seven bilaterally joined regions (amygdala, caudate nu-
cleus, hippocampus, pallidum, putamen, ventricles, whole
brain; FreeSurfer), 2) cortical thickness of four lobes and
the cingulate gyrus (FreeSurfer), 3) the volume of both
hippocampi segmented with a multi-atlas, non-local patch-
based segmentation technique (using 40 manual segmen-
tations from the Harmonized Hippocampal Protocol as at-
lases (Frisoni and Jack, 2011)), 4) two hippocampal shape
scores (left and right) computed by a Naive Bayes clas-
sifier on the principal components of surface landmarks
trained on ADNI and AIBL AD/CN data, 5) a hippocam-
pal texture score computed by a radial-basis kernel SVM
on a Gaussian-filter-bank-based texture descriptor trained
on ADNI and AIBL AD/CN data.
Classifier: Regularized linear discriminant analysis (LDA).
Diﬀerent priors were used:
1. Sørensen-equal: equal class priors
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2. Sørensen-optimized: class priors optimized on the 30
training subjects (pCN =
1
8 , pMCI =
3
8 , pAD=
1
2 ).
Training data: 504 ADNI and 145 AIBL subjects
Feature selection: -
Confounder correction: Yes. Features were z-score trans-
formed dependent on the age. Volume features were ex-
plicitly normalized by dividing by ICV.
Automatic: Yes.
Computation time: 19 hours per subject, of which 18 hours
were due to FreeSurfer processing time.
3.2.14. Tangaro et al.
Algorithm: Tangaro (Tangaro et al., 2014)
Features: Volume and cortical thickness features (FreeSurfer).
Hippocampus segmentations were obtained with random
forest classification based on Haar-like features.
Classifier: Linear SVM. Pairwise classifications were com-
bined by multiplication and normalization of the output
probabilities.
Training data: 160 ADNI subjects + the 30 training subjects
Feature selection: -
Confounder correction: -
Automatic: Yes.
Computation time: 13 hours per subject, of which 12 hours
were due to FreeSurfer processing time.
3.2.15. Wachinger et al.
Algorithm: Wachinger (Wachinger et al., 2014a)
Features: Volume, cortical thickness and shape features
(FreeSurfer). For computation of shape features, a spec-
tral shape descriptor (‘ShapeDNA’) was derived from vol-
ume (tetrahedral) and surface (triangular) meshes obtained
from FreeSurfer labels with the marching cubes algorithm.
This shape descriptor computes the intrinsic geometry
with a method that does not require alignment between
shapes (Reuter et al., 2006). Using 50 eigenvalues of the
shape descriptor, two types of shape features were com-
puted (Wachinger et al., 2014b): 1) the principal compo-
nent for 44 brain structures (‘BrainPrint’), and 2) the shape
diﬀerences between left and right for white matter, gray
matter, cerebellum white matter and gray matter, striatum,
lateral ventricles, hippocampus and amygdala.
Classifier: Generalized linear model.
Training data: 751 ADNI subjects + the 30 training subjects.
Feature selection: Five methods were used:
1. Wachinger-man: manual selection of ROIs.
2. Wachinger-step1: stepwise selection using the
Akaike information criterion on ADNI.
3. Wachinger-step2: stepwise selection using the
Akaike information criterion on ADNI and the pro-
vided training data.
4. Wachinger-step1Norm: stepwise selection using the
Akaike information criterion on ADNI with normal-
ization by the Riemannian volume of the structure.
5. Wachinger-enetNorm: elastic net regularization with
normalization by the Riemannian volume of the
structure.
Confounder correction: Yes. Age was corrected for by linear
regression, volume measures were normalized by the ICV.
Automatic: Yes.
Computation time: 17.4 hours per subject, of which 16.8
hours were due to FreeSurfer processing.
0
20
40
60
80
100
Methods (sorted on Accuracy)
Ac
cu
ra
cy
 o
r T
PF
 [%
]
 
 
So
ere
nse
n−
equ
al
So
ere
nse
n−
opt
imi
zed
Wa
chi
nge
r−e
net
No
rm
Led
ig−
AL
L
Mo
rad
i
Fra
nkeSe
nsi
Led
ig−
CO
RT
Led
ig−
GR
AD
Wa
chi
nge
r−s
tep
1
Wa
chi
nge
r−s
tep
1N
orm
Sa
rica
Wa
chi
nge
r−s
tep
2
Ab
dul
kad
ir
Led
ig−
MB
L
Wa
chi
nge
r−m
an
Es
kild
sen
−A
DN
I1
Es
kild
sen
−F
AC
EA
DN
I1
Es
kild
sen
−C
om
bin
ed
Do
lph
Ro
utie
r−a
dni
Es
kild
sen
−F
AC
EA
DN
I2
Ro
utie
r−t
rain
Led
ig−
VO
L
Es
kild
sen
−A
DN
I2
Am
oro
so
Ta
nga
ro
Ca
rde
nas
−P
enaSm
ith
Accuracy TPFCN TPFMCI TPFAD
Figure 1: Accuracy and TPFs on the test data for the participating
algorithms. For the accuracy, the 95% confidence interval is shown in
grey.
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Figure 2: Area under the ROC-curve (AUC) on the test data for the
participating algorithms. For total AUC, the 95% confidence interval
is shown in grey.
4. Results
The results presented in this section are based on the 29 algo-
rithms presented at the CADDementia workshop (Section 3).
4.1. Classification performance
Table 5 and Fig. 1 show the accuracies and TPFs for the algo-
rithms. The algorithms are ranked by accuracy. The accuracies
ranged from 32.2% to 63.0%. As a three-class classification
problemwas analyzed, the accuracy for random guessingwould
be ∼33.3%. If all subjects were estimated to be in the largest
class (CN), the accuracy would be nCN/n = 129/354 = 36.4%.
It can thus be observed that 27 out of the 29 algorithms per-
formed significantly better than guessing. The algorithm with
the best accuracy was Sørensen-equal, with an accuracy of
63.0%. According to the McNemar test, Sørensen-equal was
significantly better than most other algorithms (p < 0.05) ex-
cept for Sørensen-optimized (p = 0.23), Wachinger-enetNorm
(p = 0.21), Moradi (p = 0.14), Ledig-ALL (p = 0.09), and
Franke (p = 0.06). The TPFs had a large variability between
the algorithms, showing that the diﬀerent algorithms chose dif-
ferent priors for the classification. Appendix A lists the confu-
sion matrices for all algorithms.
For 19 of the methods, output probabilities were submitted,
enabling ROC-analysis. Table 6 and Fig. 2 show the over-
all AUC and the per-class AUCs (AUC(ci)) for the algorithms
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Table 5: Accuracy and true positive fractions (TPFs) on the test data for the participating algorithms. CI = 95% confidence interval estimated
with bootstrapping.
Rank Algorithm Accuracy [%] (CI) TPFCN [%] (CI) TPFMCI [%] (CI) TPFAD [%] (CI)
1 Sørensen-equal 63.0 (57.9 - 67.5) 96.9 (92.9 - 99.2) 28.7 (21.3 - 37.4) 61.2 (51.6 - 69.8)
2 Sørensen-optimized 59.9 (54.8 - 64.7) 70.5 (62.8 - 77.8) 41.0 (33.3 - 50.0) 68.9 (59.6 - 77.2)
3 Wachinger-enetNorm 59.0 (54.0 - 63.6) 72.1 (63.4 - 79.2) 51.6 (43.5 - 61.3) 51.5 (41.5 - 61.2)
4 Ledig-ALL 57.9 (52.5 - 62.7) 89.1 (83.7 - 93.8) 41.0 (32.4 - 49.6) 38.8 (30.7 - 50.0)
5 Moradi 57.6 (52.3 - 62.4) 57.4 (48.7 - 66.1) 59.8 (51.3 - 68.1) 55.3 (46.7 - 65.2)
6 Franke 56.2 (50.8 - 61.3) 58.9 (50.4 - 67.5) 43.4 (34.8 - 51.7) 68.0 (58.8 - 77.1)
7.5 Sensi 55.1 (50.0 - 60.2) 71.3 (63.6 - 78.8) 40.2 (31.2 - 49.6) 52.4 (42.7 - 62.0)
7.5 Ledig-CORT 55.1 (49.7 - 59.9) 68.2 (60.5 - 76.0) 45.1 (35.3 - 53.4) 50.5 (41.2 - 60.5)
9.5 Ledig-GRAD 54.0 (48.9 - 59.3) 87.6 (81.7 - 92.6) 37.7 (29.3 - 47.5) 31.1 (22.4 - 40.4)
9.5 Wachinger-step1 54.0 (48.9 - 59.0) 68.2 (60.2 - 75.4) 41.0 (31.9 - 50.9) 51.5 (42.2 - 61.1)
12.5 Wachinger-step1Norm 53.7 (48.6 - 58.8) 63.6 (54.9 - 71.9) 47.5 (38.4 - 56.6) 48.5 (39.6 - 59.1)
12.5 Sarica 53.7 (48.3 - 58.8) 65.9 (57.4 - 74.2) 39.3 (30.0 - 48.2) 55.3 (44.9 - 64.9)
12.5 Wachinger-step2 53.7 (47.5 - 58.8) 66.7 (58.1 - 74.1) 38.5 (30.1 - 48.1) 55.3 (45.5 - 65.0)
12.5 Abdulkadir 53.7 (48.3 - 58.2) 45.7 (37.0 - 53.6) 65.6 (56.1 - 73.0) 49.5 (39.4 - 58.8)
15 Ledig-MBL 53.4 (47.7 - 57.9) 82.9 (76.0 - 88.7) 43.4 (35.1 - 52.9) 28.2 (20.2 - 37.4)
16 Wachinger-man 53.1 (47.7 - 57.9) 61.2 (53.5 - 69.6) 60.7 (51.7 - 70.0) 34.0 (25.7 - 44.7)
17.5 Eskildsen-ADNI1 52.0 (46.6 - 56.8) 65.1 (56.9 - 73.2) 32.0 (24.1 - 40.9) 59.2 (49.5 - 68.3)
17.5 Eskildsen-FACEADNI1 52.0 (46.9 - 57.1) 65.1 (56.6 - 73.1) 36.1 (28.1 - 45.5) 54.4 (44.6 - 63.6)
19 Eskildsen-Combined 51.1 (45.5 - 56.2) 64.3 (56.2 - 72.3) 35.2 (27.1 - 44.3) 53.4 (43.0 - 62.9)
20 Dolph 49.7 (44.6 - 54.8) 84.5 (77.9 - 90.4) 23.0 (16.4 - 31.2) 37.9 (28.9 - 47.3)
21 Routier-adni 49.2 (43.5 - 54.2) 94.6 (89.8 - 97.7) 11.5 (6.2 - 17.7) 36.9 (27.4 - 46.5)
22.5 Eskildsen-FACEADNI2 48.3 (43.2 - 53.4) 48.8 (40.5 - 57.4) 42.6 (33.9 - 51.3) 54.4 (45.5 - 64.0)
22.5 Routier-train 48.3 (42.9 - 53.4) 48.1 (39.8 - 56.9) 21.3 (14.8 - 29.0) 80.6 (72.2 - 87.3)
24.5 Ledig-VOL 47.7 (42.1 - 52.8) 66.7 (57.1 - 74.1) 36.9 (28.9 - 45.9) 36.9 (28.6 - 47.2)
24.5 Eskildsen-ADNI2 47.7 (42.1 - 52.8) 59.7 (51.2 - 68.4) 38.5 (29.9 - 47.3) 43.7 (33.7 - 53.8)
26 Amoroso 46.9 (41.5 - 52.3) 67.4 (58.5 - 75.2) 42.6 (33.6 - 51.1) 26.2 (18.3 - 35.4)
27 Tangaro 46.6 (41.0 - 51.4) 68.2 (60.2 - 76.5) 37.7 (29.2 - 46.3) 30.1 (21.7 - 39.0)
28 Ca´rdenas-Pen˜a 39.0 (33.9 - 43.8) 50.4 (41.5 - 59.1) 28.7 (21.6 - 38.5) 36.9 (27.4 - 46.8)
29 Smith 32.2 (27.4 - 36.7) 48.1 (39.6 - 57.1) 20.5 (13.9 - 28.3) 26.2 (18.3 - 35.0)
Table 6: Area under the ROC-curve (AUC) on the test data for the participating algorithms that computed probabilistic outputs. CI = 95%
confidence interval estimated with bootstrapping.
Rank Algorithm AUC [%] (CI) AUCCN [%] (CI) AUCMCI [%] (CI) AUCAD [%] (CI)
1.5 Sørensen-equal 78.8 (75.6 - 82.0) 86.3 (81.8 - 89.3) 63.1 (56.6 - 68.3) 87.5 (83.4 - 91.1)
1.5 Sørensen-optimized 78.8 (75.5 - 82.1) 86.3 (81.9 - 89.3) 62.7 (56.8 - 68.4) 86.7 (82.3 - 90.4)
3 Abdulkadir 77.7 (74.2 - 81.0) 85.6 (81.4 - 89.0) 59.9 (54.1 - 66.4) 86.7 (82.3 - 90.3)
4 Wachinger-enetNorm 77.0 (73.6 - 80.3) 83.3 (78.5 - 87.0) 59.4 (52.9 - 65.5) 88.2 (83.8 - 91.4)
5 Ledig-ALL 76.7 (73.6 - 79.8) 86.6 (82.7 - 89.8) 59.7 (53.3 - 65.1) 84.9 (79.7 - 88.7)
6 Ledig-GRAD 75.4 (72.4 - 78.6) 85.6 (81.5 - 88.9) 60.3 (53.9 - 66.5) 81.7 (76.3 - 86.1)
7 Ledig-MBL 75.2 (72.0 - 78.1) 82.5 (77.8 - 86.0) 57.3 (50.9 - 63.6) 86.4 (81.4 - 89.9)
8 Wachinger-step1 74.6 (70.8 - 78.1) 79.1 (73.5 - 83.1) 55.0 (48.5 - 61.4) 89.2 (85.3 - 92.3)
9.5 Wachinger-step1Norm 74.3 (70.5 - 77.9) 79.3 (74.1 - 83.5) 55.5 (48.5 - 61.6) 87.7 (83.7 - 91.1)
9.5 Wachinger-man 74.3 (70.9 - 77.9) 80.6 (75.7 - 84.9) 56.3 (49.7 - 63.0) 86.1 (81.7 - 90.0)
11 Sensi 73.8 (70.2 - 77.5) 81.7 (77.1 - 85.8) 55.0 (48.8 - 61.0) 83.9 (78.8 - 87.7)
12 Ledig-CORT 73.7 (69.9 - 77.2) 79.6 (75.0 - 84.2) 58.9 (52.9 - 64.9) 82.4 (76.7 - 87.3)
13 Wachinger-step2 72.7 (68.9 - 76.4) 79.3 (74.0 - 83.5) 51.9 (45.3 - 58.7) 86.5 (81.9 - 90.3)
14 Ledig-VOL 68.4 (64.5 - 72.5) 75.7 (70.3 - 81.0) 50.1 (44.1 - 56.4) 79.0 (73.3 - 83.5)
15 Amoroso 67.2 (63.3 - 71.3) 73.4 (67.8 - 78.7) 56.0 (49.7 - 61.9) 72.3 (66.2 - 77.5)
16 Tangaro 67.1 (63.2 - 71.0) 73.1 (67.8 - 78.0) 52.6 (45.9 - 58.6) 75.8 (70.2 - 80.6)
17 Dolph 63.0 (59.6 - 67.2) 66.2 (61.3 - 70.3) 55.4 (50.0 - 60.0) 65.8 (60.6 - 71.3)
18 Ca´rdenas-Pen˜a 55.9 (51.2 - 59.9) 57.8 (51.6 - 63.4) 50.0 (43.9 - 57.1) 59.8 (53.5 - 65.7)
19 Smith 50.4 (46.7 - 54.6) 54.1 (48.0 - 60.0) 50.6 (45.0 - 57.1) 46.6 (40.0 - 53.6)
ranked by AUC. The AUC ranged from 50.4% to 78.8%. This
was better than random guessing for all algorithms except for
one having an AUC of 50.4% (46.7%-54.6%). The two algo-
rithms by Sørensen et al. (Sørensen-equal, Sørensen-optimized)
had the highest AUC (78.8%), followed by the algorithm of
Abdulkadir (AUC=77.7%). Fig. 3 shows the per-class ROC
curves for Sørensen-equal. For most algorithms, the per-class
AUCs for CN (range: 54.1%-86.6%) and AD (range: 46.6%-
89.2%) were higher than the overall AUC. Except for Smith,
AUCMCI (range: 50.0%-63.1%) was always smaller than the
overall AUC.
For the AD and CN classes, the evaluated algorithms ob-
tained relatively high values for TPF and AUC. However, TPF
and AUC for the MCI class were lower than those for the other
classes, indicating that classification of MCI based on MRI is a
diﬃcult problem. This might be due to several factors includ-
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Figure 3: The receiver-operating-characteristic (ROC) curve on all
test data for the best performing algorithm: Sørensen-equal.
ing the heterogeneity of theMCI class and the use of the clinical
diagnosis as reference standard (see Section 5.1.3).
The test data consisted of three subsets of data from three
centers (Table 2). Fig. 4 shows how the performances of the al-
gorithms varied between the subsets provided by diﬀerent cen-
ters. The performances on the UP data set were mostly higher
than those using all data, but the variation in performance across
algorithms was rather high. Performances on the VUMC data
were slightly better than those for all data, and performances on
the EMC data were slightly worse than those for all data.
4.2. Feature extraction and classifiers
As shown in Table 4, the algorithms used a wide range of
approaches. Out of the 29 methods, most methods included
features based on volume (N=19), 14 algorithms included fea-
tures based on cortical thickness, 14 algorithms included fea-
tures based on intensity (of which two algorithms used raw in-
tensities and the rest more complex intensity relations), 9 algo-
rithms included features based on shape, and 3 algorithms used
voxel-based morphometry (VBM). Volume, cortical thickness,
intensity and shape features were often combined. The combi-
nation of volume, cortical thickness and intensity was most of-
ten used (N=8). We noted from Fig. 5 that the performance dif-
ferences between the diﬀerent feature extraction strategies were
small, but in general we observed that the best performances
were achieved with VBM and the combination of volume and
cortical thickness with either shape, intensity or both. Also the
classifiers diﬀered between the algorithms: 14 algorithms used
regression, 7 algorithms used an SVM classifier, 6 used a ran-
dom forest classifier, 2 used linear discriminant analysis (LDA)
and 1 used a neural network for classification. Performance dif-
ferences between the diﬀerent classifiers seemed to be small. It
should be noted, however, that one should be careful in draw-
ing conclusions based on Table 4 or Fig. 5, as there are multiple
diﬀerences between the algorithms.
Eight teams incorporated age eﬀects in their algorithms, ei-
ther by explicitly including age in the model (Franke and Gaser,
2014; Sarica et al., 2014; Smith et al., 2014) or by eliminating
age eﬀects using age-dependent normalization (Sørensen et al.,
2014) or regression (Abdulkadir et al., 2014; Eskildsen et al.,
2014; Moradi et al., 2014; Wachinger et al., 2014a). Three
teams used the same strategy to correct for sex (Abdulkadir
et al., 2014; Eskildsen et al., 2014; Sarica et al., 2014), two
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Figure 5: Mean accuracy and area under the ROC-curve (AUC) on the
test data for the diﬀerent types of features used by the algorithms. The
error bars show the standard deviation.
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Figure 6: The number of training data sets used plotted against the test
set performance of every algorithm: (a) Accuracy, (b) Area under the
ROC-curve (AUC). The error bars show the 95% confidence interval.
teams trained separate models for males and females (Franke
and Gaser, 2014; Smith et al., 2014).
4.3. Training data
Most algorithms, except for Dolph, were trained on more
training data than only the 30 provided data sets. Mainly data
from ADNI and AIBL were used. Fig. 6 shows the relationship
between the number of training data sets and the test set perfor-
mance. Most algorithms used 600-800 data sets for training.
Fig. 7 shows the relationship between the accuracy of the
algorithms on the test set and the accuracy on the 30 provided
training data sets as reported in the workshop papers. The figure
shows that almost all algorithms overestimated accuracy on the
training set. However, some of the methods explicitly trained
on the 30 provided data sets to ensure optimal performance on
the test set. It should be noted that diﬀerent strategies were used
to evaluate the training set accuracy, i.e. train-test evaluation or
cross-validation.
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Figure 7: Accuracies for each algorithm estimated on the provided
training data plotted against the final accuracy. The error bars show
the 95% confidence interval on the test data. The black line (y = x)
indicates the expected relationship.
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Figure 4: Accuracy (a) and area under the ROC-curve (AUC) (b) on the test data for the participating algorithms on all data (N=354) and on
the three subsets of test data from diﬀerent centers: VUMC (N=166), EMC (N=161), UP (N=27). For accuracy and AUC on all data, the 95%
confidence interval is shown in grey.
5. Discussion
5.1. Evaluation framework
Although the literature on computer-aided diagnosis of de-
mentia has shown promising results, thorough validation of
these algorithms for clinical use has rarely been performed. To
enable proper validation of the algorithms, we addressed the
following factors in our evaluation framework: comparability,
generalizability and clinical applicability.
5.1.1. Comparability
Comparison of diﬀerent state-of-the-art algorithms is diﬃ-
cult, as most studies use diﬀerent evaluation data sets, valida-
tion strategies and performance measures. According to the lit-
erature, little has been done in comparing diﬀerent algorithms
using the same data and methodology. We found two stud-
ies that compared multiple algorithms (Cuingnet et al., 2011;
Sabuncu and Konukoglu, 2014), of which the work of Cuingnet
et al. (2011) does not allow addition of newmethods to the com-
parison. For our evaluation framework, we aimed to increase
comparability of the evaluated algorithms by making the test-
ing data set and the validation scripts publicly available. Eﬀort
was made to compose a large multi-center data set and to define
good evaluation criteria for multi-class classification. One of
the main advantages of this evaluation framework is that it can
be used by every researcher: anyone who developed a new al-
gorithm can download the data and submit results via our web-
based framework12. Both established and state-of-the-art algo-
rithms can be evaluated and compared to algorithms evaluated
by others. The framework remains open for new submissions.
Since the main question that we aimed to address with this
framework is how well the current state-of-the-art methods
would perform in clinical practice, we specifically chose to use
few constraints for the participating methods. Therefore, the
framework allows to compare algorithms performing the full
analysis, from image to diagnosis. This introduces a lot of
variation in the participating algorithms. Participants had a lot
of freedom in their choices for the training data and the meth-
ods for image processing and classification. Therefore, in dis-
cussing the methods we were not able to completely explain the
12http://caddementia.grand-challenge.org
performance diﬀerences between methods in all cases. For ex-
ample, a very good method that uses a small amount of training
data may have the same performance as another method that is
worse but uses more training data. With the chosen set-up, it is
also not possible to assess which part of the algorithm led to the
increase in performance. These include a multitude of aspects,
such as feature extraction, feature selection, and classification.
At present, a similar challenge is running: the Alzheimer’s
Disease Big Data (ADBD) DREAM Challenge #113, of which
sub-challenge 3 is similar to the work presented in this paper. In
the ADBD DREAM challenge, participants are asked to build a
predictive model for MMSE and diagnosis based on T1w MRI
data and other variables (i.e., age at baseline, years of education,
sex, APOE4 genotype, imputed genotypes). One of the diﬀer-
ences with our challenge is that the ADBD DREAM challenge
supplies a fixed training set from the ADNI database, instead
of leaving this open to the participants. Two test sets, both
consisting of 107 subjects from the AddNeuroMed database
(Lovestone et al., 2009) are provided. The ADBD DREAM
challenge generally made the same choices for their evaluation
framework, as they use the same diagnostic groups and ref-
erence standard. Preliminary results for the ADBD DREAM
challenge are available from their web site. The best predictive
model for MMSE yielded a Pearson correlation of 0.602, and
the best model for diagnosis yielded an accuracy of 60.2%. The
algorithm that was best ranked on average used Gaussian pro-
cess regression with 20 image features, APOE4 and education
(Fan and Guan, 2014).
5.1.2. Generalizability
For new methods, it is important to know how they would
generalize to a new, clinically representative data set. Often
cross-validation is used to validate the performance of machine
learning algorithms (Falahati et al., 2014). Although cross-
validation is very useful, especially in the situation when not
many scans are available, it optimizes performance on a specific
population and can therefore overestimate performance on the
general population (Adaszewski et al., 2013). In addition, algo-
rithms are often tuned to specific cohorts which limits their gen-
eralizability (Adaszewski et al., 2013). When generalizing an
13http://www.synapse.org/#!Synapse:syn2290704/
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algorithm to other data, variability in the data acquisition pro-
tocol, the population or the reference standard can be problem-
atic and can decrease performance (Sabuncu and Konukoglu,
2014). To evaluate generalizability of the algorithms, which is
certainly required for clinical implementation, we used a large,
new and unseen test set in this work. This data set consisted
of scans acquired with GE (n=354) and Siemens (n=30) scan-
ners, so we do not have information on the performance of
the algorithms on data from other scanners. However, the data
set had some diﬀerences in scanning parameters, which allows
evaluation of the generalizability of the algorithms to diﬀerent
scanning protocols. The diagnostic labels of the test set were
blinded to the authors of the algorithms, which is diﬀerent from
the benchmark papers by Cuingnet et al. (2011) and Sabuncu
and Konukoglu (2014). The importance of an independent test
is also confirmed by Fig. 7, which shows that all algorithms
overestimated the performance by cross-validating or tuning on
the training set.
Another factor providing insight into the generalizability of
the performance results was the size of the test set. The test
set was quite large, consisting of 354 subjects. Not many
other studies used an unseen test set. For studies using cross-
validation, usually 500-800 data sets from the ADNI database
are used (Cuingnet et al., 2011; Falahati et al., 2014; Sabuncu
and Konukoglu, 2014). The ADBD DREAM challenge uses an
unseen test set, but much smaller than the one used here (107
subjects).
5.1.3. Clinical applicability
For this evaluation framework, the decision was made to split
our multi-center data set into a small (n=30) training set and a
large test set. This choice resembles a clinical setting, where in
a certain hospital only a small training data set is available. On
the other hand, a lot of training data are available from publicly
available databases like the ADNI and AIBL, which can be used
for training the algorithms.
As reference standard for evaluation of the algorithms, the
current clinical diagnosis criteria for AD (McKhann et al.,
2011) and MCI (Petersen, 2004) were used, which is common
practice in studies of computer-aided diagnosis methods (Cu-
ingnet et al., 2011; Klo¨ppel et al., 2008; Falahati et al., 2014;
Davatzikos et al., 2008a; Duchesne et al., 2008; Fan et al.,
2008a,b; Gray et al., 2013; Koikkalainen et al., 2012; Magnin
et al., 2009; Vemuri et al., 2008; Wolz et al., 2011). Ground
truth diagnosis of dementia can only be assessed using autopsy
and is therefore only rarely available. Of the previously men-
tioned papers, only one paper included one group of 20 AD
patients with an autopsy confirmed diagnosis (Klo¨ppel et al.,
2008). Amyloid imaging (Klunk et al., 2004) has also proven to
be a good biomarker for AD, as subjects with positive amyloid
showed to have a more rapid disease progression (Jack et al.,
2010). However, availability of these data is also very limited.
The limitation of using clinical diagnosis as the ground truth is
that it may be incorrect. In the literature, the reported accura-
cies of the clinical diagnosis of AD, based on the old criteria
(McKhann et al., 1984), compared to postmortem neuropatho-
logical gold standard diagnosis were in the range of 70-90%
(Mattila et al., 2012; Lim et al., 1999; Petrovitch et al., 2001;
Kazee et al., 1993). Although the clinical diagnosis has limita-
tions, we believe it is the best available reference standard. One
should also note that this challenge does not aim to assess the
diagnostic accuracy of structural MRI, as MRI itself is also in-
cluded in the criteria for clinical diagnosis. Instead, we focus on
comparing computer-aided diagnosis algorithms on an unseen
blinded test set with standardized evaluation methods using the
clinical diagnosis as the best available reference standard.
This work interprets the diﬀerentiation of patients with AD,
MCI and controls as a multi-class classification problem. This
might not be optimal as there is an ordering of the classes, i.e.
classification of an AD patient as an MCI patient might be less
bad than classifying as a healthy person. However, addressing
only binary problems, such as AD/CN classification, does not
reflect the clinical diagnosis making and results in a too opti-
mistic performance estimate. Because the current clinical diag-
nosis uses the three classes, we chose to focus on multi-class
classification in this challenge and did not use the ordering in
the evaluation.
According to the criteria of Petersen (2004) and similar to
ADNI, only MCI patients with memory complaints, amnestic
MCIs, were included in the data set. For classification, all MCI
patients were considered to be a single group which is accord-
ing to current clinical practice (Petersen, 2004). This is debat-
able, since MCI patients are known to be a clinically hetero-
geneous group with diﬀerent patterns of brain atrophy (Misra
et al., 2009), of which some cases will not progress to AD.
From this point of view, it can be questioned whether MCI is
a diagnostic entity or whether MCI describes a stage on a con-
tinuum from cognitively normal to AD. If MCI is actually an
intermediate between the two other classes, the AD/CN border
in three-class classification would be also subject to discussion.
Although the usage of the MCI definition is advised for diag-
nosis in clinical practice (Petersen, 2004), the borders between
AD/MCI and MCI/CN based on diagnostic criteria can be un-
clear. Because of those unclear borders and the heterogeneity
in the MCI class, classification accuracies are expected to be
reduced. The results of the evaluated algorithms confirmed that
distinguishing MCI from AD and CN is diﬃcult. The AUC for
all algorithms was the lowest for the MCI class and in most
cases also TPF was the lowest for MCI. Despite these limita-
tions, the same choices for the reference standard, classifica-
tion, and the MCI group were made in the ADBD DREAM
challenge. Moreover, since MCI is still used as diagnostic label
in current clinical practice, having an objective and automated
algorithm that makes such diagnosis based on structural MRI,
would already be useful, for example, as a second opinion.
For facilitating clinical implementation of the algorithms, it
would be a great benefit to make the evaluated algorithms pub-
licly available for enabling validation on other data without the
need for reimplementation. In our evaluation framework, this
is not yet possible. Instead, in our framework, all teams were
encouraged to make a step-by-step implementation guide14 to
make it possible to run the submitted algorithms on other data
sets.
5.2. Evaluated algorithms and results
The best performing algorithm (Sørensen-equal: accuracy =
63.0%, AUC = 78.8%) was based on a combination of fea-
tures and used a simple linear classifier (LDA). Also, regarding
the other top-ranked algorithms, the best performances were
achieved by algorithms that incorporated features describing
diﬀerent properties of the scans. Although the performance
diﬀerences between the diﬀerent feature extraction strategies
were small, algorithms that used shape or intensity features in
addition to regional volumes and thickness performed slightly
better than algorithms solely based on shape features or on vol-
ume features. The VBM-based methods also performed well.
14http://caddementia.grand-challenge.org/wiki
14
Diﬀerent multivariate analysis techniques were used by the al-
gorithms, mainly regression, SVM, and random forest classi-
fiers. No trend in the best performing type of classifier could be
found.
Since hardly any results for three-class classification have
been reported, we cannot compare with representative results
from the literature. The TPFs and AUCs for the AD and CN
classes in this work are a bit lower than those reported previ-
ously for AD/CN classification (Falahati et al., 2014), but we
expect that this is mainly due to the additional MCI class in the
classification and its heterogeneity. The ADBD Dream chal-
lenge also evaluated three-class classification, and it reported
performances similar to those of this study (see Section 5.1.1).
The methods Sørensen-equal and Sørensen-optimized were
ranked highest both based on accuracy and AUC. In general,
the rankings by the two performance measures were similar,
but there were some exceptions. Abdulkadir, for example,
ranked much higher based on AUC (rank=3) than on accuracy
(rank=12.5), which means that this method was capable of dis-
tinguishing the classes with high sensitivity and specificity at
diﬀerent cut-oﬀ points. However, for measuring the accuracy,
not the optimal cut-oﬀ point was chosen by the classifier. The
accuracy of this method could be improved by optimizing the
class priors used by the classifier. For classification, it is gener-
ally assumed that the training data and its class priors are repre-
sentative for the test data. Depending on the class distributions
of the training data used, this assumption on class priors might
not always have been justified. On the other hand, it is diﬃcult
to correct for diﬀerences in class priors, as the distribution of
the test set is often unknown. Of the participating teams, two
specifically took the issue of class priors into account. Eskild-
sen et al. removed the class unbalance of the training set using
a resampling technique (Eskildsen et al., 2014; Chawla et al.,
2002). Sørensen et al. experimented with two sets of class
priors: equal class priors and class priors optimized on the 30
training subjects (Sørensen et al., 2014). However, for most
algorithms accuracy and AUC were similar, indicating that rea-
sonable assumptions on the class priors were made.
The provided data set consisted of structural MRI scans from
three centers. We noticed a small performance diﬀerence be-
tween the three subsets. The performance on the UP subset was
the highest, but this might be explained by chance given the
small size of the UP data set (n=27 in the test set, n=3 in the
training set) and a slight selection bias towards more clinically
clear-cut cases. Between the two other subsets, a minor perfor-
mance diﬀerence could be noted. The performance diﬀerences
might be caused by slight diﬀerences in inclusion criteria, used
scanners and scanning protocols between the centers, empha-
sizing the importance of a multi-center test set.
The size of the training set is known to have a large influence
on the performance of the classifier (Falahati et al., 2014). Al-
though this study does not provide enough information to draw
a valid conclusion, as we evaluated only 29 algorithms with the
majority of training sets consisting of 600-800 subjects, we see
a slight positive relation between the number of training data
sets and the test set performance.
The mean age of AD patients in the used data set was
66.1 ± 5.2 years, whereas the age for AD patients in the ADNI
cohorts that were used by many algorithms for training was
about 10 years higher (Abdulkadir et al., 2014; Amoroso et al.,
2014; Eskildsen et al., 2014; Ledig et al., 2014; Sarica et al.,
2014; Sensi et al., 2014; Sørensen et al., 2014;Wachinger et al.,
2014a). Although the same diagnosis criteria were used in both
cohorts, this age diﬀerence is most probably due to selection
bias. The used dataset consists of clinical data representing
the outpatient clinic population, whereas ADNI consists of re-
search data. For clinical practice, MRI may be used more con-
servatively. In addition, there is a referral bias towards younger
patients because the VUMC and the EMC are tertiary centers
specialized in presenile dementia. This age diﬀerence between
training and test data might have had a negative eﬀect on the
performances found in this study. To take this into account,
eight of the 15 teams incorporated age eﬀects in their algo-
rithms.
5.3. Recommendations for future work
This challenge provided insight on the best strategies for
computer-aided diagnosis of dementia and on the performance
of such algorithms on an independent clinically representative
data set. However, for this challenge, specific choices for the
evaluation framework were made. Therefore, for clinical im-
plementation of such algorithms, more validation studies that
explore variations of this challenge are necessary.
A limitation of this challenge is that the clinical diagnosis
is used as reference standard. For the clinical diagnosis, MCI
is used as a diagnostic entity; it could however be questioned
whether this can exist as separate diagnosis next to AD. In ad-
dition, the accuracy of the clinical diagnosis is limited, but data
sets with better reference standards are scarce. The best refer-
ence standard is the postmortem diagnosis based on pathology,
which is the ground truth for AD diagnosis. A good alternative
would be a reference standard based on the clinical diagnosis
including amyloid biomarkers or a long-term follow-up. For a
validation study, we strongly recommend to have an indepen-
dent test set with blinded diagnostic labels to promote general-
izability.
In this challenge, classification was based on structural MRI
using subject age and sex as the only additional information.
For a future challenge in which ground truth diagnosis is used
for reference, it would be very interesting to use all avail-
able clinical data in addition to structural MRI as input for
the computer-aided diagnosis algorithms. For the current chal-
lenge, this was not yet useful as the reference standard was
based directly on these clinical data. For structural MRI, this
is not a problem as it is only used qualitatively in clinical diag-
nosis making.
For the current work, we adopted hardly any constraints re-
sulting in a wide range of participating algorithms. To aid
the understanding of the influence of certain methodological
choices on the algorithm performance, new projects could de-
cide to focus on comparing specific elements of the algorithms.
We cannot be sure that the included algorithms are the best
currently available. Although this challenge was broadly adver-
tised, quite some eﬀort from participants was required which
may have kept some researchers from participating. Of the
teams that submitted a proposal, two thirds did not participate
in the challenge, possibly due to lack of time or resources. To
reach a wider audience in future challenges, organizers could
reduce the eﬀort required from participants, for example by pro-
viding precomputed features.
Another interesting problem to address in a future challenge
is that of diﬀerential diagnosis of AD and other types of demen-
tia (e.g., frontotemporal dementia (Du et al., 2006; Davatzikos
et al., 2008b; Raamana et al., 2014) or Lewy body dementia
(Lebedev et al., 2013)). In addition, instead of evaluating di-
agnostic algorithms, evaluation of prognostic algorithms would
be very useful. Future challenges could therefore evaluate the
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classification of MCI patients that convert to AD and MCI pa-
tients that do not convert to AD within a certain time period.
Lastly, new projects could request their participants to make
their algorithms publicly available to facilitate clinical imple-
mentation of the algorithms for computer-aided diagnosis.
6. Conclusion
We presented a framework for the comparison of algorithms
for computer-aided diagnosis of AD and MCI using structural
MRI data and used it to compare 29 algorithms submitted by
15 research teams. The framework defines evaluation criteria
and provides a previously unseen multi-center data set with the
diagnoses blinded to the authors of the algorithms. The results
of this framework therefore present a fair comparison of algo-
rithms for multi-class classification of AD, MCI and CN. The
best algorithm, developed by Sørensen et al., yielded an accu-
racy of 63% and an AUC of 78.8%. Although the performance
of the algorithms was influenced by many factors, we noted
that the best performance was generally achieved by methods
that used a combination of features.
The evaluation framework remains open for new submis-
sions to be added to the ranking. We refer interested readers
to the web site http://caddementia.grand-challenge.org, where
instructions for participation can be found.
We believe that public large-scale validation studies, such as
this work, are an important step towards the introduction of
high-potential algorithms for computer-aided diagnosis of de-
mentia into clinical practice.
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Appendix A. Confusion matrices of the algorithms
Sørensen-equal True class
CN MCI AD
CN 125 64 15
Hypothesized class MCI 3 35 25
AD 1 23 63
Sørensen-optimized True class
CN MCI AD
CN 91 37 5
Hypothesized class MCI 33 50 27
AD 5 35 71
Wachinger-enetNorm True class
CN MCI AD
CN 93 44 6
Hypothesized class MCI 36 63 44
AD 0 15 53
Ledig-ALL True class
CN MCI AD
CN 115 57 16
Hypothesized class MCI 14 50 47
AD 0 15 40
Moradi True class
CN MCI AD
CN 74 30 2
Hypothesized class MCI 52 73 44
AD 3 19 57
Franke True class
CN MCI AD
CN 76 48 12
Hypothesized class MCI 44 53 21
AD 9 21 70
Sensi True class
CN MCI AD
CN 92 45 9
Hypothesized class MCI 36 49 40
AD 1 28 54
Ledig-CORT True class
CN MCI AD
CN 88 49 18
Hypothesized class MCI 32 55 33
AD 9 18 52
Ledig-GRAD True class
CN MCI AD
CN 113 59 19
Hypothesized class MCI 15 46 52
AD 1 17 32
Wachinger-step1 True class
CN MCI AD
CN 88 57 7
Hypothesized class MCI 40 50 43
AD 1 15 53
Wachinger-step1Norm True class
CN MCI AD
CN 82 49 7
Hypothesized class MCI 47 58 46
AD 0 15 50
Sarica True class
CN MCI AD
CN 85 43 11
Hypothesized class MCI 41 48 34
AD 3 29 57
Wachinger-step2 True class
CN MCI AD
CN 86 51 4
Hypothesized class MCI 41 47 42
AD 2 24 57
Abdulkadir True class
CN MCI AD
CN 59 19 2
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